Acutus Medical (AFIB) IPO Opens 34% Higher

Today's IPO for Acutus Medical, Inc. (NASDAQ: AFIB) opened for trading at $24.11 after pricing 8,823,529 shares of its common stock at a price to the public of $18.00 per share. All of the shares are being offered by Acutus.

In addition, Acutus has granted the underwriters a 30-day option to purchase up to an additional 1,323,529 shares of Acutus’ common stock at the initial public offering price, less the underwriting discounts and commissions.

J.P. Morgan and BofA Securities are acting as joint book-running managers. William Blair is also acting as book-running manager. Canaccord Genuity and BTIG are acting as co-managers.

Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

You May Also Be Interested In

• SK hynix files for Nasdaq IPO under ticker symbol SKHY
• Definium Therapeutics prices $700M public offering at $34 per share
• Doncasters Group guiding IPO pricing at top of range - Bloomberg